Immunic
IMUX
66 hedge funds and large institutions have $153M invested in Immunic in 2020 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 26 increasing their positions, 8 reducing their positions, and 11 closing their positions.
255% more call options, than puts
Call options by funds: $2.22M | Put options by funds: $625K
225% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 8
199% more capital invested
Capital invested by funds: $51M → $153M (+$102M)
145% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 11
29% more funds holding
Funds holding: 51 → 66 (+15)
1.31% more ownership
Funds ownership: 2.81% → 4.12% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$14.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.1M |
| 3 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$6.82M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.59M |
| 5 |
Millennium Management
New York
|
+$5.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$2.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.12M |
| 3 |
Renaissance Technologies
New York
|
-$2.04M |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.98M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.49M |
IMUX Hedge Fund Activity: Q3 2020 in Review
66 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2020, worth a combined $153M — up 199% from $51M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new IMUX positions and 11 closed out — a net gain of 16 holders — while 26 added to existing stakes and 8 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $14.9M. The largest seller was Granite Point Capital Management, exiting entirely with an estimated $2.4M sold.
- 66 institutional investors held Immunic (IMUX) as of Q3 2020, up from 51 in Q2 2020.
- Funds reported $153M of Immunic stock for Q3 2020, up 199% quarter-over-quarter.
- 27 funds opened new Immunic positions in Q3 2020 and 11 closed out, a net change of +16 holders.
- The largest Immunic buyer in Q3 2020 was RTW Investments, an estimated $14.9M added.
- The largest Immunic seller in Q3 2020 was Granite Point Capital Management, an estimated $2.4M sold.
Based on aggregated 13F filings for Q3 2020.